Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for PLAGL1
Z-value: 3.14
Motif logo
Transcription factors associated with PLAGL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PLAGL1
|
ENSG00000118495.20 | PLAGL1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PLAGL1 | hg38_v1_chr6_-_144008364_144008388 | 0.60 | 5.1e-04 | Click! |
Activity profile of PLAGL1 motif
Sorted Z-values of PLAGL1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of PLAGL1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 23.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 3.8 | 11.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 3.7 | 14.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 3.6 | 18.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 3.5 | 21.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 3.4 | 10.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 3.1 | 9.4 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 3.0 | 17.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 3.0 | 8.9 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 2.9 | 41.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.9 | 8.7 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 2.8 | 8.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 2.7 | 21.2 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 2.5 | 7.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 2.4 | 7.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 2.4 | 7.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.4 | 26.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 2.3 | 20.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.2 | 15.2 | GO:0030421 | defecation(GO:0030421) |
| 2.2 | 8.6 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 2.1 | 10.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 2.1 | 6.3 | GO:0097187 | dentinogenesis(GO:0097187) |
| 2.1 | 6.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 2.0 | 6.0 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 2.0 | 20.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 2.0 | 15.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 2.0 | 2.0 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 2.0 | 9.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.9 | 5.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 1.9 | 5.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.9 | 9.4 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.9 | 7.5 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.9 | 22.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 1.8 | 7.2 | GO:1990834 | response to odorant(GO:1990834) |
| 1.8 | 1.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.8 | 12.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 1.8 | 1.8 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.8 | 7.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 1.8 | 7.0 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.7 | 14.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.7 | 8.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 1.7 | 17.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 1.7 | 20.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.7 | 30.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.7 | 6.8 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.7 | 8.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 1.6 | 3.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 1.6 | 9.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.6 | 1.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.6 | 4.8 | GO:0014028 | notochord formation(GO:0014028) |
| 1.6 | 4.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 1.6 | 12.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.6 | 6.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.6 | 9.5 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 1.6 | 1.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.6 | 1.6 | GO:0097017 | renal protein absorption(GO:0097017) |
| 1.6 | 15.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 1.5 | 6.2 | GO:0002384 | hepatic immune response(GO:0002384) |
| 1.5 | 6.2 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.5 | 6.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 1.5 | 9.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.5 | 12.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 1.5 | 4.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.5 | 9.1 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.5 | 17.8 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.5 | 5.9 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.5 | 11.8 | GO:0015705 | iodide transport(GO:0015705) |
| 1.5 | 5.9 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.5 | 4.4 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 1.5 | 4.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.5 | 1.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 1.4 | 8.6 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 1.4 | 5.8 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 1.4 | 9.9 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 1.4 | 4.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.4 | 1.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 1.4 | 7.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.4 | 5.6 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 1.4 | 2.8 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 1.4 | 6.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 1.4 | 4.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.4 | 6.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.3 | 4.0 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 1.3 | 8.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 1.3 | 6.7 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 1.3 | 4.0 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 1.3 | 5.3 | GO:0033122 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 1.3 | 6.6 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 1.3 | 6.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.3 | 3.9 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 1.3 | 10.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 1.3 | 12.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.3 | 8.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 1.2 | 7.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 1.2 | 1.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.2 | 4.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) positive regulation of prolactin secretion(GO:1902722) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.2 | 7.3 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 1.2 | 6.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.2 | 1.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 1.2 | 7.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.2 | 7.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.2 | 2.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.2 | 3.5 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.1 | 2.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 1.1 | 6.7 | GO:0032252 | secretory granule localization(GO:0032252) |
| 1.1 | 1.1 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.1 | 1.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.1 | 5.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.1 | 3.3 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 1.1 | 1.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 1.1 | 13.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.1 | 4.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 1.1 | 4.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.1 | 4.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 1.1 | 5.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 1.1 | 13.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.1 | 3.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 1.0 | 3.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) negative regulation of membrane tubulation(GO:1903526) |
| 1.0 | 3.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 1.0 | 3.1 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 1.0 | 3.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.0 | 1.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 1.0 | 6.2 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.0 | 5.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.0 | 2.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.0 | 3.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.0 | 1.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 1.0 | 5.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 1.0 | 18.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 1.0 | 4.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 1.0 | 2.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.0 | 4.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.0 | 7.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.0 | 4.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.0 | 5.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 1.0 | 3.0 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 1.0 | 4.9 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.0 | 8.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.0 | 12.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.0 | 3.9 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 1.0 | 5.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.0 | 26.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.9 | 2.8 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.9 | 0.9 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.9 | 4.7 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.9 | 5.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.9 | 25.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.9 | 5.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.9 | 0.9 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.9 | 2.8 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.9 | 3.7 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.9 | 3.7 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.9 | 2.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.9 | 5.5 | GO:0060356 | leucine import(GO:0060356) |
| 0.9 | 5.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.9 | 1.8 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.9 | 1.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.9 | 1.8 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.9 | 3.5 | GO:0042335 | cuticle development(GO:0042335) |
| 0.9 | 5.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.9 | 2.6 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.9 | 2.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.9 | 1.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.9 | 3.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.9 | 12.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.9 | 1.7 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.9 | 2.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.9 | 4.3 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.9 | 3.5 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.9 | 2.6 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 | 2.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.9 | 11.1 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.9 | 1.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.8 | 3.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.8 | 4.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.8 | 5.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.8 | 0.8 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.8 | 8.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.8 | 9.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.8 | 2.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.8 | 2.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.8 | 2.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.8 | 2.5 | GO:0090273 | positive regulation of pancreatic juice secretion(GO:0090187) regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.8 | 5.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.8 | 3.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.8 | 1.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.8 | 9.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.8 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 | 2.4 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.8 | 2.4 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.8 | 7.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.8 | 2.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.8 | 5.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.8 | 19.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.8 | 3.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.8 | 1.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.8 | 4.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.8 | 15.0 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.8 | 1.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.8 | 13.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.8 | 2.3 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.8 | 0.8 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.8 | 12.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.8 | 5.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.8 | 3.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.8 | 2.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.8 | 3.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.8 | 3.9 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.8 | 8.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.8 | 2.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.8 | 2.3 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.8 | 3.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.8 | 3.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.8 | 6.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.8 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.8 | 3.0 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.8 | 3.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.8 | 2.3 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.8 | 8.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.7 | 5.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.7 | 5.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.7 | 1.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.7 | 3.0 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.7 | 1.5 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.7 | 2.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.7 | 2.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.7 | 3.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.7 | 3.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.7 | 2.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.7 | 0.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.7 | 2.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.7 | 0.7 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.7 | 9.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.7 | 5.7 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.7 | 1.4 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.7 | 3.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.7 | 0.7 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.7 | 3.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.7 | 4.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.7 | 2.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.7 | 3.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.7 | 4.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 | 4.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.7 | 6.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.7 | 4.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.7 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.7 | 2.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.7 | 9.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.7 | 20.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.7 | 1.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.7 | 6.7 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.7 | 8.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.7 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.7 | 7.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.7 | 9.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.7 | 8.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.7 | 14.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.7 | 4.6 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.7 | 3.3 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.7 | 10.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.7 | 2.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.7 | 9.8 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.7 | 2.0 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.7 | 0.7 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.7 | 3.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.6 | 1.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.6 | 2.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 5.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.6 | 3.8 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.6 | 1.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.6 | 2.5 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.6 | 1.9 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.6 | 2.5 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.6 | 3.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.6 | 2.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.6 | 3.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.6 | 2.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.6 | 3.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.6 | 8.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.6 | 12.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.6 | 1.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.6 | 1.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.6 | 3.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.6 | 11.6 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.6 | 2.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.6 | 1.8 | GO:0035788 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.6 | 1.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.6 | 2.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.6 | 1.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.6 | 3.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.6 | 3.0 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.6 | 0.6 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.6 | 4.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.6 | 21.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.6 | 4.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.6 | 5.3 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.6 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.6 | 3.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.6 | 15.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.6 | 1.2 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.6 | 0.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.6 | 5.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.6 | 2.9 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.6 | 1.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.6 | 13.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.6 | 2.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.6 | 1.7 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.6 | 4.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 | 1.7 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 0.6 | 9.0 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.6 | 1.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.6 | 2.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.6 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.6 | 2.2 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.6 | 6.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.6 | 5.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.6 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 | 2.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.6 | 7.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.6 | 11.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.5 | 2.7 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.5 | 6.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.5 | 1.6 | GO:0071486 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
| 0.5 | 21.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.5 | 8.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.5 | 4.9 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.5 | 2.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.5 | 2.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.5 | 1.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
| 0.5 | 1.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.5 | 1.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.5 | 1.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.5 | 1.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.5 | 1.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.5 | 3.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.5 | 2.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 | 2.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.5 | 5.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.5 | 3.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.5 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.5 | 2.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.5 | 1.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.5 | 4.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.5 | 2.1 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.5 | 2.6 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.5 | 3.2 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 0.5 | 4.2 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.5 | 3.2 | GO:0045914 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.5 | 4.7 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.5 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 0.5 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.5 | 2.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.5 | 3.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.5 | 1.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.5 | 8.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.5 | 2.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.5 | 1.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.5 | 3.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.5 | 5.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 | 4.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.5 | 1.0 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.5 | 0.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.5 | 1.0 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.5 | 0.5 | GO:0003193 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.5 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.5 | 1.5 | GO:0018194 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.5 | 2.0 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.5 | 5.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.5 | 1.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.5 | 4.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.5 | 10.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.5 | 1.0 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.5 | 3.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.5 | 1.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.5 | 1.5 | GO:0019089 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.5 | 0.5 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.5 | 4.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.5 | 2.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.5 | 3.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.5 | 1.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.5 | 22.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.5 | 1.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.5 | 1.0 | GO:0043586 | tongue development(GO:0043586) |
| 0.5 | 1.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.5 | 5.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.5 | 3.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.5 | 2.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.5 | 6.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.5 | 0.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.5 | 1.0 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.5 | 1.4 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.5 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.5 | 5.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.5 | 1.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.5 | 1.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.5 | 4.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.5 | 1.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.5 | 7.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.5 | 2.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.5 | 0.5 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.5 | 5.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
| 0.5 | 8.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.5 | 0.9 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.5 | 1.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.5 | 2.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 | 1.9 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.5 | 1.4 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.5 | 7.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.5 | 1.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.5 | 1.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.5 | 5.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.5 | 2.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.5 | 1.8 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.5 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.5 | 2.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.5 | 3.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.5 | 5.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.5 | 1.8 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.5 | 4.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.5 | 2.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.5 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.5 | 1.8 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.5 | 0.9 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.4 | 2.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.4 | 2.7 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.4 | 2.7 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.4 | 2.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.4 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.4 | 0.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.4 | 4.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.4 | 2.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.4 | 2.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.4 | 1.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 | 1.3 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.4 | 7.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.4 | 3.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.4 | 6.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 | 1.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 2.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.4 | 1.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 | 1.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 5.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.4 | 1.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.4 | 1.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 2.1 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
| 0.4 | 5.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.4 | 1.7 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 0.9 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
| 0.4 | 4.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.4 | 2.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.4 | 1.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.4 | 2.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.4 | 1.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.4 | 2.9 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.4 | 1.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 | 4.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 | 0.8 | GO:0097106 | postsynaptic density organization(GO:0097106) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.4 | 7.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.4 | 9.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.4 | 3.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 | 1.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.4 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 | 1.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.4 | 1.6 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.4 | 6.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.4 | 1.2 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.4 | 1.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 | 15.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.4 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.4 | 3.6 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.4 | 1.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 | 1.2 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.4 | 2.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.4 | 1.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.4 | 1.6 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 8.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.4 | 2.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.4 | 3.9 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.4 | 2.0 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.4 | 2.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.4 | 0.8 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.4 | 0.4 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.4 | 1.9 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 | 0.8 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.4 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 | 0.4 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.4 | 1.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.4 | 3.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.4 | 1.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 1.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.4 | 3.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 0.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.4 | 0.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 0.4 | 2.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.4 | 9.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.4 | 2.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.4 | 1.5 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.4 | 1.5 | GO:0003285 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
| 0.4 | 1.1 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.4 | 4.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.4 | 1.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 | 0.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.4 | 2.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 | 5.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.4 | 0.7 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.4 | 1.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.4 | 4.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.4 | 3.3 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.4 | 0.7 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.4 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 | 4.4 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
| 0.4 | 1.8 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.4 | 1.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.4 | 1.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 | 0.4 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.4 | 1.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.4 | 1.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.4 | 1.8 | GO:0046874 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
| 0.4 | 6.5 | GO:0060022 | hard palate development(GO:0060022) |
| 0.4 | 7.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.4 | 7.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.4 | 0.4 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
| 0.4 | 4.7 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.4 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.4 | 1.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.4 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.4 | 3.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.4 | 7.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 0.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.4 | 1.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.4 | 2.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 4.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 4.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.4 | 1.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 | 5.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 0.7 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.4 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.4 | 1.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.3 | 3.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 1.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 | 0.7 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 | 1.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 | 1.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.3 | 1.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.3 | 4.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.3 | 13.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.3 | 4.1 | GO:0030578 | PML body organization(GO:0030578) |
| 0.3 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 | 2.4 | GO:0060613 | fat pad development(GO:0060613) |
| 0.3 | 1.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.3 | 2.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.3 | 1.0 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.3 | 4.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.3 | 1.0 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 | 1.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.3 | 3.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 2.3 | GO:0046618 | drug export(GO:0046618) |
| 0.3 | 1.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 | 3.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 1.3 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 | 2.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 3.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.3 | 1.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 | 2.0 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.3 | 1.3 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.3 | 2.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 | 8.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.3 | 1.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.3 | 1.9 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 | 1.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.3 | 8.1 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.3 | 1.3 | GO:2000662 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 0.3 | 1.9 | GO:0097384 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular lipid biosynthetic process(GO:0097384) |
| 0.3 | 1.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.3 | 0.6 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 | 1.3 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.3 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 1.9 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.3 | 1.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 | 5.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.3 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 | 0.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 | 6.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.3 | 3.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.3 | 3.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 0.9 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 2.5 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.3 | 1.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 0.3 | GO:0046051 | UTP metabolic process(GO:0046051) |
| 0.3 | 1.9 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 6.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 2.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.3 | 0.9 | GO:1904640 | response to methionine(GO:1904640) |
| 0.3 | 4.0 | GO:0030903 | notochord development(GO:0030903) |
| 0.3 | 4.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 1.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 0.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.3 | 1.9 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.3 | 0.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.3 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.3 | 0.6 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.3 | 13.2 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 | 0.3 | GO:1901491 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 | 4.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.3 | 1.8 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.3 | 3.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 2.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 0.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 | 6.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.3 | 0.9 | GO:0010933 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.3 | 2.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 | 2.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.3 | 3.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 | 2.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 | 0.6 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.3 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
| 0.3 | 0.9 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.3 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.3 | 0.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.3 | 1.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.3 | 3.9 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.3 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 0.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.3 | 1.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.3 | 1.2 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.3 | 2.3 | GO:0048535 | lymph node development(GO:0048535) |
| 0.3 | 2.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 | 2.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.3 | 0.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 | 1.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.3 | 0.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.3 | 0.3 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.3 | 2.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.3 | 0.6 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.3 | 0.9 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.3 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 | 2.6 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
| 0.3 | 24.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.3 | 2.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.3 | 0.9 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.3 | 0.6 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.3 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 0.8 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.3 | 1.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.3 | 1.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.3 | 1.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 | 3.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.3 | 0.3 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 | 6.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 1.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.3 | 0.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 | 1.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.3 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 3.8 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.3 | 3.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.3 | 2.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.3 | 3.8 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.3 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.3 | 0.8 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.3 | 2.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 2.4 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.3 | 3.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 | 0.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.3 | 1.1 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.3 | 1.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.3 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 4.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.3 | 6.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 1.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 | 2.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.3 | 1.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.3 | 2.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.3 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 1.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.3 | 1.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.3 | 3.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.3 | 4.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 | 3.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.3 | 1.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.3 | 0.8 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.3 | 2.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 | 4.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.3 | 1.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.3 | 2.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 0.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.3 | 2.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 7.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 | 5.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.3 | 0.8 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 2.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.3 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 1.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 | 4.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.3 | 1.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 | 5.1 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.3 | 2.3 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
| 0.3 | 1.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.3 | 4.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.3 | 0.8 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.2 | 0.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.2 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 | 9.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 7.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.2 | 2.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 | 0.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.2 | 4.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 1.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 4.4 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.2 | 1.2 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.2 | 3.4 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.2 | 1.0 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 5.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 1.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 19.2 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.2 | 0.5 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 1.0 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 | 1.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.2 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 4.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 3.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
| 0.2 | 3.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 0.7 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 | 0.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 | 9.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.2 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 | 1.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 3.8 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
| 0.2 | 1.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 | 1.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.2 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.2 | 4.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 | 7.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 1.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
| 0.2 | 2.6 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.2 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 | 4.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 | 3.3 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.2 | 9.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.2 | 0.9 | GO:0060065 | uterus development(GO:0060065) |
| 0.2 | 0.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.2 | 0.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 0.2 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 0.2 | 3.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.2 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.2 | 1.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.2 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 3.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.2 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 1.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 3.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 0.5 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.2 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 0.5 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
| 0.2 | 1.1 | GO:0007135 | meiosis II(GO:0007135) |
| 0.2 | 2.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.2 | 15.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.2 | 1.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 0.9 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 | 1.1 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.2 | 1.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.2 | 1.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.2 | 0.9 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 0.9 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 3.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 2.9 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.2 | 2.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.2 | 0.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 | 2.0 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 0.4 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.2 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.2 | 0.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.2 | 1.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.2 | 2.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 1.3 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.2 | 0.9 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
| 0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 1.7 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.2 | 0.2 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.2 | 2.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 | 7.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 1.7 | GO:0009750 | response to fructose(GO:0009750) |
| 0.2 | 5.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 5.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 | 1.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.2 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 0.8 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 0.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.2 | 2.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 | 2.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 1.2 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 2.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.2 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.2 | 2.5 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.2 | 1.0 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 6.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.2 | 1.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 1.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 3.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 0.8 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.2 | 3.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.2 | 0.4 | GO:0048308 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.2 | 0.4 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 | 1.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.2 | 5.8 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.2 | 0.8 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.2 | 0.8 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.2 | 4.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.2 | 3.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 2.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 1.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 0.4 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.2 | 2.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 | 1.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.2 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) germ-line stem cell population maintenance(GO:0030718) |
| 0.2 | 1.8 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.2 | 1.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 1.5 | GO:0007512 | adult heart development(GO:0007512) |
| 0.2 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.2 | 1.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.2 | 2.7 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
| 0.2 | 1.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.2 | 3.4 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
| 0.2 | 0.8 | GO:0046645 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) positive regulation of gamma-delta T cell activation(GO:0046645) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.2 | 1.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 2.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 1.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 0.4 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.2 | 2.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.2 | 1.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.2 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 3.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 0.6 | GO:1903542 | epidermal growth factor catabolic process(GO:0007174) negative regulation of exosomal secretion(GO:1903542) |
| 0.2 | 0.2 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 3.2 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.2 | 3.9 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 1.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 0.9 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.2 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.2 | 7.9 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.2 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 0.5 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.2 | 6.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
| 0.2 | 2.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.2 | 1.6 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.2 | 2.7 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.2 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 | 1.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 | 0.5 | GO:0061573 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.2 | 4.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 | 5.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 | 0.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.2 | 0.5 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 0.7 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 3.0 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.2 | 1.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 0.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 1.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 | 2.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.2 | 0.3 | GO:0050976 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 0.9 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.2 | 1.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 1.7 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 | 5.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 0.7 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.2 | 1.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.2 | 0.7 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.2 | 0.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.2 | 2.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 | 2.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 0.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.2 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 | 0.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
| 0.2 | 3.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 2.9 | GO:0006757 | ATP generation from ADP(GO:0006757) |
| 0.2 | 1.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.2 | 1.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.2 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 | 3.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 | 0.5 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.2 | 0.8 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.2 | 16.4 | GO:0070268 | cornification(GO:0070268) |
| 0.2 | 1.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 0.5 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.2 | 2.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.2 | 1.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 1.1 | GO:0032196 | transposition(GO:0032196) |
| 0.2 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 3.1 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.2 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.3 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
| 0.2 | 1.8 | GO:0048265 | response to pain(GO:0048265) |
| 0.2 | 0.8 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.2 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
| 0.2 | 1.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 0.9 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 1.2 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.2 | 0.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.2 | 0.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 1.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.2 | 0.8 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.2 | 9.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 5.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.2 | 0.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.2 | 1.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 | 7.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 | 0.8 | GO:2000846 | regulation of corticosteroid hormone secretion(GO:2000846) |
| 0.1 | 3.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 1.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.1 | 0.4 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.1 | 3.7 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 9.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.3 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 0.9 | GO:0032620 | interleukin-17 production(GO:0032620) |
| 0.1 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 3.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 0.4 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 2.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 1.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 3.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 3.6 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 2.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 8.5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 1.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.9 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.1 | 1.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 2.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 | 0.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 1.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 | 2.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.8 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 0.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 5.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 0.4 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 | 2.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 2.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.7 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.7 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 | 0.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 | 0.3 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.1 | 0.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.1 | 0.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 1.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 7.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 2.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 1.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 2.4 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 15.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 0.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.4 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 | 1.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 9.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 | 3.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 2.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 | 0.6 | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) |
| 0.1 | 1.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.1 | 1.7 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 1.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 0.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.8 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.1 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 1.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.1 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.1 | 1.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.2 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 | 0.7 | GO:0071941 | urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.1 | 0.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.1 | 0.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
| 0.1 | 6.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.1 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 1.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 0.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 | 1.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 0.7 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.1 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 | 0.2 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 | 0.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.1 | 0.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 1.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.3 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 | 0.8 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.1 | 2.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.1 | 2.1 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 1.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 1.0 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.1 | 0.5 | GO:0019563 | glycerol catabolic process(GO:0019563) glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.9 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.2 | GO:0051891 | cardiac left ventricle formation(GO:0003218) positive regulation of cardioblast differentiation(GO:0051891) |
| 0.1 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.1 | 0.2 | GO:0034397 | telomere localization(GO:0034397) |
| 0.1 | 0.1 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.1 | 0.5 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 | 0.8 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.1 | 0.6 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 | 0.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.3 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.1 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 0.2 | GO:0021593 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
| 0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 3.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 | 0.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.1 | 0.2 | GO:0003230 | cardiac atrium development(GO:0003230) |
| 0.1 | 1.4 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 1.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.1 | 1.4 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 1.2 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
| 0.1 | 0.5 | GO:0010814 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) trachea cartilage morphogenesis(GO:0060535) |
| 0.1 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 4.2 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.1 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 | 3.0 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.1 | 0.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 0.3 | GO:1901162 | putrescine transport(GO:0015847) primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 | 1.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 1.1 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.8 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.1 | 1.1 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
| 0.1 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.1 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 2.0 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 1.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 4.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.8 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 0.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.6 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
| 0.1 | 1.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 4.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 | 0.6 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.1 | 0.1 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.1 | 0.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.1 | 3.9 | GO:0007292 | female gamete generation(GO:0007292) |
| 0.1 | 0.2 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.1 | 4.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.3 | GO:0034093 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 0.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 | 0.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.2 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 1.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 7.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 0.9 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 1.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 1.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.2 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 | 0.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.1 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.2 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.1 | 1.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.6 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.1 | 0.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 1.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.9 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.1 | 1.0 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.6 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.1 | 0.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.1 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 1.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.1 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
| 0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 1.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.8 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 0.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 | 0.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 2.4 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 0.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.2 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.1 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.1 | 0.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 | 2.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 1.6 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.1 | 0.5 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.1 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.1 | 0.6 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 | 0.9 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) regulation of macrophage colony-stimulating factor production(GO:1901256) |
| 0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.1 | 0.2 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 | 1.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 1.5 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.2 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.0 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 | 10.2 | GO:0007015 | actin filament organization(GO:0007015) |
| 0.0 | 0.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 | 0.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.4 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.8 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.0 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
| 0.0 | 0.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 | 0.2 | GO:0032913 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.0 | 0.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 1.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.0 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.0 | 0.7 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.1 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.0 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 0.4 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.0 | 0.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.4 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
| 0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 | 0.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.2 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
| 0.0 | 1.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.0 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.0 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 | 0.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.0 | 0.1 | GO:0001910 | regulation of leukocyte mediated cytotoxicity(GO:0001910) |
| 0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
| 0.0 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.0 | 0.3 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
| 0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
| 0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 | 0.1 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
| 0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.0 | 0.1 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
| 0.0 | 2.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.0 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.0 | 0.1 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.0 | 0.3 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.0 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.5 | GO:0008585 | female gonad development(GO:0008585) |
| 0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.0 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.0 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
| 0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 11.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 3.6 | 18.1 | GO:0032449 | CBM complex(GO:0032449) |
| 3.1 | 9.4 | GO:0032127 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.5 | 17.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.5 | 7.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 2.4 | 7.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.3 | 11.7 | GO:0031523 | Myb complex(GO:0031523) |
| 2.3 | 6.8 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 2.1 | 10.5 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.8 | 7.0 | GO:1990032 | parallel fiber(GO:1990032) |
| 1.7 | 5.2 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 1.7 | 10.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 1.7 | 25.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.5 | 5.9 | GO:0097229 | sperm end piece(GO:0097229) |
| 1.5 | 4.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 1.5 | 13.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.4 | 6.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 1.3 | 1.3 | GO:0051286 | cell tip(GO:0051286) |
| 1.2 | 5.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.2 | 4.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.2 | 31.3 | GO:0005922 | connexon complex(GO:0005922) |
| 1.2 | 4.6 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.1 | 5.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.1 | 5.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 1.0 | 4.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.0 | 5.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.0 | 23.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.0 | 4.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.0 | 5.8 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.9 | 2.8 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.9 | 0.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.9 | 10.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.9 | 4.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.9 | 0.9 | GO:1902710 | GABA receptor complex(GO:1902710) |
| 0.9 | 5.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.9 | 8.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.9 | 2.6 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.9 | 4.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.8 | 2.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.8 | 3.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.8 | 2.5 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.8 | 1.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.8 | 25.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.8 | 14.5 | GO:0045180 | basal cortex(GO:0045180) |
| 0.8 | 9.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.8 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.8 | 6.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.8 | 2.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.8 | 4.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.7 | 2.2 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.7 | 5.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.7 | 7.9 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.7 | 6.4 | GO:0043256 | laminin complex(GO:0043256) |
| 0.7 | 2.8 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.7 | 9.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.7 | 4.9 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.7 | 1.4 | GO:0005883 | neurofilament(GO:0005883) |
| 0.7 | 7.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.7 | 0.7 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.7 | 2.0 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.7 | 6.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.7 | 7.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.7 | 2.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.7 | 11.8 | GO:0008091 | spectrin(GO:0008091) |
| 0.6 | 1.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.6 | 3.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 1.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.6 | 7.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.6 | 1.9 | GO:1990742 | microvesicle(GO:1990742) |
| 0.6 | 1.9 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.6 | 12.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.6 | 2.6 | GO:0044393 | microspike(GO:0044393) |
| 0.6 | 5.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.6 | 5.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.6 | 4.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.6 | 4.8 | GO:0000796 | condensin complex(GO:0000796) |
| 0.6 | 1.8 | GO:0097409 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 0.6 | 3.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.6 | 2.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.6 | 2.2 | GO:0000811 | GINS complex(GO:0000811) |
| 0.6 | 5.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.5 | 5.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.5 | 4.7 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.5 | 2.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.5 | 15.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.5 | 5.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.5 | 1.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.5 | 8.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.5 | 2.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.5 | 3.5 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.5 | 11.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.5 | 4.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.5 | 2.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.5 | 1.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.5 | 4.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.5 | 1.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.5 | 4.3 | GO:0071546 | pi-body(GO:0071546) |
| 0.5 | 1.9 | GO:0016342 | catenin complex(GO:0016342) |
| 0.5 | 1.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.5 | 1.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.5 | 0.5 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.4 | 2.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.4 | 2.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.4 | 3.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.4 | 1.8 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.4 | 7.4 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 9.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.4 | 1.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.4 | 5.1 | GO:0032059 | bleb(GO:0032059) |
| 0.4 | 1.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.4 | 9.6 | GO:0042627 | chylomicron(GO:0042627) |
| 0.4 | 7.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.4 | 5.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 1.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.4 | 5.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.4 | 3.3 | GO:0031415 | NatA complex(GO:0031415) |
| 0.4 | 12.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 19.7 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 3.6 | GO:0070449 | elongin complex(GO:0070449) |
| 0.4 | 1.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.4 | 1.2 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.4 | 6.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 7.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.4 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
| 0.4 | 3.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 6.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.4 | 3.8 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.4 | 1.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 2.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 3.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.4 | 5.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.4 | 1.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.4 | 1.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 0.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.4 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.4 | 7.7 | GO:0000800 | lateral element(GO:0000800) |
| 0.4 | 7.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.4 | 5.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.4 | 1.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.4 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.4 | 1.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.4 | 4.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.4 | 5.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.4 | 7.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.4 | 19.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 1.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.3 | 2.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.3 | 0.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.3 | 29.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.3 | 5.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.3 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.3 | 1.0 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.3 | 4.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.3 | 0.7 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.3 | 3.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.3 | 1.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 1.9 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.3 | 55.9 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.3 | 0.3 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.3 | 2.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 5.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 0.3 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.3 | 6.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 2.4 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.3 | 7.3 | GO:1990752 | microtubule end(GO:1990752) |
| 0.3 | 2.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 4.0 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.3 | 6.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.3 | 190.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
| 0.3 | 16.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 1.8 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 1.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.3 | 1.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.3 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.3 | 8.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.3 | 1.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.3 | 3.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.3 | 1.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.3 | 7.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 2.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.3 | 0.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.3 | 10.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.3 | 4.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.3 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 1.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.3 | 4.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 1.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.3 | 4.6 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.3 | 1.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 1.9 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 6.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 22.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.3 | 1.1 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.3 | 1.6 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.3 | 2.6 | GO:0042641 | actomyosin(GO:0042641) |
| 0.3 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.3 | 6.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.3 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 24.0 | GO:0005604 | basement membrane(GO:0005604) |
| 0.3 | 3.3 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
| 0.2 | 7.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 21.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 3.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.2 | 1.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 2.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 1.9 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.2 | 2.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.2 | 0.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 0.7 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.2 | 1.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.2 | 7.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.2 | 1.8 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.2 | 8.6 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 2.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 2.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 1.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.2 | 2.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 22.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 4.9 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.2 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.2 | 0.8 | GO:0005816 | spindle pole body(GO:0005816) |
| 0.2 | 10.3 | GO:0001726 | ruffle(GO:0001726) |
| 0.2 | 1.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 0.8 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.2 | 2.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.2 | 8.7 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.2 | 1.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.2 | 4.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 20.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 3.3 | GO:0033643 | host cell part(GO:0033643) |
| 0.2 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 2.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.2 | 0.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.2 | 0.6 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.2 | 7.3 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 8.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.2 | 3.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 4.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.2 | 4.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 5.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 12.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 13.4 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.2 | 20.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 3.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 41.2 | GO:0045121 | membrane raft(GO:0045121) |
| 0.2 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 1.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 17.0 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 2.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.2 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 3.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.2 | 2.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 6.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.2 | 3.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.2 | 2.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 1.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.2 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.2 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 3.7 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.2 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
| 0.2 | 1.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.2 | 24.5 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 1.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.2 | 1.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 17.0 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.2 | 2.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.2 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 29.5 | GO:0031968 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
| 0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 7.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 3.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 2.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.1 | 22.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.1 | 0.5 | GO:1990879 | CST complex(GO:1990879) |
| 0.1 | 0.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 2.0 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.1 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 5.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 1.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 1.8 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 2.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 7.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 8.3 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 5.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 1.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 7.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 6.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 14.9 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 11.1 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.1 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 13.7 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.2 | GO:0044309 | neuron spine(GO:0044309) |
| 0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 6.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 2.9 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 0.4 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 2.2 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.1 | 0.1 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 0.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.1 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 8.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.4 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 8.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 7.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 1.8 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.1 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.1 | 5.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
| 0.1 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 3.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.3 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 3.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 1.0 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
| 0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 0.3 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.4 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 1.5 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 0.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 3.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.0 | 0.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.0 | 0.5 | GO:0070187 | telosome(GO:0070187) |
| 0.0 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 2.6 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.0 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.0 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.0 | 4.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 3.4 | GO:0070161 | anchoring junction(GO:0070161) |
| 0.0 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.0 | 7.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.0 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 9.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 1.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 11.2 | GO:0005730 | nucleolus(GO:0005730) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 23.9 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 3.6 | 14.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 3.1 | 12.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 2.9 | 8.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 2.8 | 8.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 2.6 | 7.9 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 2.4 | 14.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 2.4 | 7.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 2.3 | 16.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 2.2 | 8.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 2.2 | 6.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 2.2 | 8.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 2.1 | 10.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 2.1 | 14.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 2.1 | 6.2 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 2.0 | 5.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.8 | 9.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.8 | 5.4 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 1.8 | 7.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 1.8 | 8.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.8 | 5.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 1.8 | 8.8 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 1.7 | 1.7 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 1.7 | 6.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 1.7 | 8.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 1.7 | 8.4 | GO:0030395 | lactose binding(GO:0030395) |
| 1.7 | 1.7 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.7 | 8.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 1.7 | 5.0 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 1.6 | 8.2 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.6 | 4.8 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 1.6 | 4.8 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.6 | 6.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.6 | 14.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.5 | 4.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 1.5 | 4.4 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 1.5 | 4.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 1.5 | 5.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.4 | 5.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.4 | 5.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.4 | 26.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 1.4 | 24.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.4 | 19.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.4 | 2.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.3 | 8.1 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 1.3 | 6.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.3 | 6.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 1.3 | 3.9 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 1.3 | 14.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.3 | 24.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.3 | 5.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 1.2 | 6.2 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.2 | 3.7 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 1.2 | 4.9 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.2 | 2.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.2 | 3.6 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 1.2 | 7.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 1.2 | 1.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 1.2 | 5.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 1.1 | 3.4 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 1.1 | 4.4 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 1.1 | 6.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 1.1 | 11.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.1 | 11.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 1.1 | 18.1 | GO:0048185 | activin binding(GO:0048185) |
| 1.1 | 6.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.0 | 6.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 1.0 | 5.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.0 | 5.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 1.0 | 3.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 1.0 | 12.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 1.0 | 3.0 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 1.0 | 3.0 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 1.0 | 2.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 1.0 | 2.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.0 | 7.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.0 | 2.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.0 | 4.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 1.0 | 1.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 1.0 | 9.6 | GO:0034618 | arginine binding(GO:0034618) |
| 0.9 | 7.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.9 | 6.5 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.9 | 3.7 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.9 | 7.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.9 | 18.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.9 | 3.5 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.9 | 5.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.8 | 4.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.8 | 3.4 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.8 | 5.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.8 | 6.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.8 | 2.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.8 | 2.4 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.8 | 4.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.8 | 9.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.8 | 21.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.8 | 4.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.8 | 2.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.8 | 7.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.8 | 3.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.8 | 6.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.8 | 3.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.8 | 3.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.8 | 8.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.8 | 14.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.8 | 3.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.8 | 3.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.8 | 3.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.8 | 3.0 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.8 | 7.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.7 | 2.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.7 | 3.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.7 | 11.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.7 | 11.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.7 | 6.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.7 | 7.3 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.7 | 5.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.7 | 2.2 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.7 | 5.0 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.7 | 2.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.7 | 2.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.7 | 6.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.7 | 2.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.7 | 4.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.7 | 4.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.7 | 2.1 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.7 | 3.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.7 | 2.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.7 | 2.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.7 | 2.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.7 | 4.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.7 | 2.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.7 | 8.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.7 | 2.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.7 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.7 | 1.3 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.7 | 3.3 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.7 | 3.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.7 | 1.3 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.7 | 3.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 5.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.6 | 4.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.6 | 3.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.6 | 3.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.6 | 1.3 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.6 | 1.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.6 | 10.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.6 | 12.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.6 | 2.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.6 | 3.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.6 | 5.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.6 | 3.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.6 | 2.5 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 10.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.6 | 3.7 | GO:0042835 | BRE binding(GO:0042835) |
| 0.6 | 2.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.6 | 4.3 | GO:0005497 | androgen binding(GO:0005497) |
| 0.6 | 3.7 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.6 | 22.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.6 | 1.2 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 5.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.6 | 3.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.6 | 6.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.6 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
| 0.6 | 6.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.6 | 5.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.6 | 6.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.6 | 27.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.6 | 6.4 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.6 | 15.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.6 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.6 | 1.7 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.6 | 2.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.6 | 3.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.6 | 12.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.6 | 0.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.6 | 2.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.6 | 2.3 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.6 | 4.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.6 | 1.7 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.6 | 2.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.6 | 3.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.6 | 2.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.5 | 21.4 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.5 | 2.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.5 | 11.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.5 | 1.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.5 | 7.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.5 | 2.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.5 | 10.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.5 | 170.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.5 | 12.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.5 | 4.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.5 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.5 | 1.6 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.5 | 2.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.5 | 7.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.5 | 2.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.5 | 4.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.5 | 2.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.5 | 1.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.5 | 12.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.5 | 5.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.5 | 3.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.5 | 7.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.5 | 1.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.5 | 15.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.5 | 4.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.5 | 1.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.5 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.5 | 2.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.5 | 1.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.5 | 2.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.5 | 3.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.5 | 4.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 4.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.5 | 2.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.5 | 1.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.5 | 4.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.5 | 1.9 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.5 | 1.4 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.5 | 3.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.5 | 1.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.5 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.5 | 1.4 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.5 | 10.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.5 | 9.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.5 | 5.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.5 | 0.9 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.5 | 1.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.5 | 1.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.5 | 0.9 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.5 | 0.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.5 | 3.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.5 | 0.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.5 | 1.8 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.4 | 1.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.4 | 14.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.4 | 2.7 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.4 | 4.4 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 22.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.4 | 3.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.4 | 1.8 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.4 | 0.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.4 | 3.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 4.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.4 | 1.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.4 | 21.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.4 | 4.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.4 | 3.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.4 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.4 | 1.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.4 | 1.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.4 | 8.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.4 | 1.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.4 | 2.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
| 0.4 | 7.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.4 | 23.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.4 | 4.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.4 | 3.6 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.4 | 3.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.4 | 7.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.4 | 2.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.4 | 1.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 2.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.4 | 14.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.4 | 1.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.4 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.4 | 4.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 3.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.4 | 2.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.4 | 1.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 9.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.4 | 1.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.4 | 1.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.4 | 1.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.4 | 4.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.4 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.4 | 4.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.4 | 2.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.4 | 4.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.4 | 0.7 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.4 | 2.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.4 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 3.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.4 | 7.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 8.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 1.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.4 | 1.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.4 | 1.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.4 | 2.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 1.1 | GO:0001034 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.4 | 13.2 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.4 | 3.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.4 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.4 | 2.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.4 | 10.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.4 | 2.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.4 | 1.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.4 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.4 | 0.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.4 | 6.7 | GO:0005522 | profilin binding(GO:0005522) |
| 0.4 | 3.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.4 | 13.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.4 | 0.4 | GO:0000035 | acyl binding(GO:0000035) |
| 0.3 | 2.1 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.3 | 1.0 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.3 | 6.9 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 1.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 2.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 5.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 1.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.3 | 1.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.3 | 43.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 7.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.3 | 4.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 2.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.3 | 2.0 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.3 | 1.0 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.3 | 7.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.3 | 4.0 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.3 | 3.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.3 | 9.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.3 | 53.2 | GO:0005178 | integrin binding(GO:0005178) |
| 0.3 | 2.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 2.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.3 | 4.9 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 3.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 8.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.3 | 1.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.3 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.3 | 1.0 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.3 | 1.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.3 | 2.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 2.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.3 | 1.9 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 3.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.3 | 4.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 1.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.3 | 1.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 2.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.3 | 1.3 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.3 | 1.9 | GO:0004096 | catalase activity(GO:0004096) |
| 0.3 | 0.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.3 | 12.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.3 | 36.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.3 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.3 | 3.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 7.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 4.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.3 | 4.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.3 | 0.3 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.3 | 5.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.3 | 4.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 30.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.3 | 5.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 4.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 0.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.3 | 1.2 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.3 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.3 | 0.9 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 0.3 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 3.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.3 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.3 | 1.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 2.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.3 | 1.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.3 | 3.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.3 | 3.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 7.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 0.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.3 | 19.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.3 | 2.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 2.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 1.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.3 | 1.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.3 | 0.8 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.3 | 2.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.3 | 1.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.3 | 2.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 1.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.3 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.3 | 1.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.3 | 13.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 1.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.3 | 6.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.3 | 2.7 | GO:0031386 | protein tag(GO:0031386) |
| 0.3 | 2.1 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 4.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.3 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.3 | 4.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.3 | 1.9 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.3 | 2.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.3 | 0.8 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.3 | 10.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.3 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 1.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.3 | 4.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.3 | 1.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 9.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.3 | 3.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.3 | 2.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 1.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 1.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 3.7 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 2.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.2 | 2.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 1.0 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.2 | 2.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.2 | 1.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 0.5 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 0.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 1.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 0.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 12.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.2 | 2.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 6.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 2.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.2 | 0.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.2 | 6.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.2 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) rhodopsin kinase activity(GO:0050254) |
| 0.2 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 3.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.2 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 1.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.2 | 2.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 0.9 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 2.7 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 3.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.2 | 8.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.2 | 2.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.2 | 0.9 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.2 | 32.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.2 | 25.7 | GO:0005179 | hormone activity(GO:0005179) |
| 0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 0.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.2 | 1.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 2.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 0.7 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.2 | 0.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 2.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.2 | 16.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.2 | 1.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.2 | 0.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.2 | 15.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.2 | 3.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 0.6 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 2.5 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.2 | 40.4 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.2 | 1.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.2 | 1.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 1.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 0.6 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.2 | 0.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 4.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 0.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 4.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 8.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 2.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.2 | 20.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.2 | 23.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 0.8 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.2 | 0.6 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.2 | 2.1 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 0.8 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.2 | 5.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 2.6 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.2 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.2 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 4.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 0.6 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.2 | 1.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 0.4 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.2 | 1.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 0.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 2.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 1.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.2 | 0.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 0.2 | 1.9 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 1.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 1.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.2 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.2 | 6.6 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.2 | 6.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.9 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.2 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.2 | 0.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 3.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 2.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 3.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 6.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.2 | 2.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.2 | 0.7 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.2 | 1.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 1.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 1.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.2 | 3.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 65.9 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.2 | 0.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.2 | 3.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.2 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.2 | 5.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 1.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 2.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 0.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 1.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 0.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 4.5 | GO:0005549 | odorant binding(GO:0005549) |
| 0.2 | 0.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.2 | 7.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 1.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.2 | 0.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
| 0.2 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 1.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.1 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.1 | 0.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.0 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 0.6 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.1 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 1.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 7.8 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 4.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 0.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 4.5 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 0.3 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 2.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.1 | 0.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.1 | 2.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.1 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 2.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.1 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 1.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.1 | 0.4 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.1 | 4.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 1.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 1.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 6.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.1 | 0.4 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.1 | 5.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 3.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 1.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.1 | 0.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 0.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 2.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 2.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 2.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 4.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 1.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 25.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 1.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.1 | 1.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 1.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
| 0.1 | 0.3 | GO:0052830 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.1 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.2 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 0.9 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 4.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 4.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.1 | 2.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 8.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.1 | 0.4 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 0.3 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
| 0.1 | 1.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.1 | 0.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.1 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 1.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 0.9 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 1.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 1.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 3.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 0.3 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.1 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.1 | 9.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.1 | 3.7 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 1.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 1.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 1.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.6 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 0.1 | 2.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
| 0.1 | 2.7 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.8 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 5.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 0.2 | GO:0070697 | activin receptor binding(GO:0070697) |
| 0.1 | 0.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 0.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.1 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 1.8 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 0.2 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.1 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 1.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 2.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 1.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
| 0.1 | 0.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.8 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 1.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 2.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.1 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.2 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.1 | 7.6 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
| 0.1 | 2.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.1 | 0.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 1.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.1 | 0.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.1 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.0 | 0.1 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.0 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.0 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.0 | 6.1 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.0 | 0.2 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.0 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.0 | 2.1 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 1.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.0 | 2.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 2.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.3 | GO:0015278 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 2.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 2.0 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.0 | 1.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 2.4 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 0.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 1.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 1.2 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 4.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.0 | 0.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 3.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 1.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 1.2 | 23.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.1 | 15.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.8 | 34.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.8 | 52.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.8 | 54.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.8 | 13.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.7 | 20.2 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.7 | 28.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.6 | 5.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.6 | 28.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.6 | 13.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.5 | 34.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.5 | 26.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.5 | 5.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.5 | 5.5 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.5 | 6.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.5 | 32.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.4 | 6.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.4 | 4.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.4 | 20.4 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 15.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.4 | 13.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.4 | 123.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.4 | 14.3 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.4 | 17.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.4 | 4.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.4 | 4.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 1.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 15.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.3 | 28.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 6.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 12.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 2.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.3 | 6.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.3 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 7.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.3 | 7.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 5.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 11.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.3 | 9.3 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 3.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.3 | 4.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.3 | 8.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 8.9 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.3 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.3 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.2 | 3.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 4.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 7.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 1.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 5.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 2.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 7.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.2 | 7.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 6.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 9.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 10.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 7.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 7.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 12.0 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 6.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 12.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.2 | 20.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 10.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 10.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 3.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 3.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 4.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 7.0 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 7.8 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 3.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 6.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 1.8 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 1.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 3.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 2.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 3.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 6.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 8.9 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 5.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 2.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 1.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 5.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 3.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 42.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 5.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 2.7 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 2.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 5.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 1.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 3.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 2.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 11.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 3.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 31.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 1.1 | 19.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 1.0 | 26.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 1.0 | 2.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.0 | 22.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.9 | 0.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.9 | 2.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.8 | 21.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.8 | 52.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.8 | 20.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.8 | 17.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.8 | 13.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.8 | 12.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.7 | 11.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.7 | 5.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.7 | 3.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.7 | 8.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.7 | 35.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.7 | 11.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.6 | 19.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.6 | 11.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.6 | 23.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.6 | 17.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.6 | 22.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.5 | 9.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.5 | 11.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 26.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.5 | 7.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.5 | 10.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.5 | 16.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.5 | 1.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.5 | 10.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.5 | 7.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.5 | 5.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.5 | 7.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.5 | 8.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.5 | 6.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.5 | 8.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.5 | 13.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.5 | 18.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.5 | 9.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.4 | 34.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.4 | 10.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.4 | 3.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.4 | 10.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.4 | 6.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 14.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.4 | 13.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.4 | 3.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.4 | 11.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.4 | 6.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.4 | 6.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.4 | 12.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.4 | 24.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.4 | 5.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.4 | 3.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 6.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 9.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.3 | 4.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 6.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 4.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.3 | 10.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.3 | 5.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.3 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.3 | 4.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 2.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 6.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 2.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.3 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.3 | 19.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.3 | 4.5 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.3 | 3.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.3 | 4.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.3 | 0.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.3 | 4.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.3 | 18.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.3 | 7.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.3 | 28.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.3 | 4.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.3 | 10.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.3 | 5.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 11.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 5.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 4.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 2.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.3 | 12.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.3 | 0.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.3 | 10.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.3 | 4.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 3.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.3 | 7.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 6.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 19.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.2 | 25.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 11.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 10.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.2 | 2.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.2 | 4.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 2.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.2 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 8.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 6.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.2 | 7.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.2 | 5.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.2 | 9.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 2.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 3.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 11.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 3.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 4.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 1.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 2.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 3.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.2 | 3.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.2 | 5.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 46.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 5.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.2 | 5.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.2 | 2.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.2 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.2 | 6.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 2.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 4.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.2 | 2.6 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 2.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 12.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 4.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.2 | 4.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 4.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 4.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.2 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 5.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 3.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.2 | 4.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 1.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.2 | 29.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.2 | 5.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 1.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 3.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 2.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.2 | 5.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 2.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 6.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 4.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 24.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
| 0.1 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 5.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 1.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 1.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 5.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 8.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 3.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 2.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 3.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 4.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.1 | 4.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.1 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 1.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 4.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 4.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 0.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 4.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 2.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 3.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
| 0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 5.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 6.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 1.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 5.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 1.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 1.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 4.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
| 0.0 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 4.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 8.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 1.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.0 | 1.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 0.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.0 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
| 0.0 | 0.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |